Morton Grove Pharmaceuticals
Commitment to Public Health and Safety
Morton Grove Pharmaceuticals, Inc. (MGP) is a specialty pharmaceutical company headquartered in Illinois, and is one of the leading manufacturers of generic prescription oral liquid and topical medications in the U.S. The company employs more than 260 professionals in the areas of research and development, compliance, regulatory affairs, manufacturing, distribution, and sales. As the sole U.S. manufacturer of lindane lotion and lindane shampoo, MGP has worked with the Food and Drug Administration (FDA) to advance the safety and usefulness of this second-line medication.
A portfolio of therapies that benefit public health
A strong commitment to quality manufacturing and research and development has enabled MGP to help lead the industry in providing the healthcare community and the public with affordable generic liquid prescription medications.
- More than 65 different prescription therapies are owned and developed by MGP—the majority are cost-saving generics
- Core therapeutics are manufactured at MGP’s 125,000 square foot, state-of-the-art facility located in Morton Grove, Illinois, with another research facility in Vernon Hills, Illinois
- Research and development efforts are supported by the innovation of more than 30 R&D scientists and more than 260 employees overall
| MGP therapies are used in many different areas of medicine | |
|---|---|
|
|
Continued investments in lindane safety
MGP recognizes the public health need to preserve lindane as a second-line therapy and has already taken important measures to minimize the risk for product misuse. In consultation with regulatory experts, MGP has also initiated an extensive and rigorous lindane clinical research program. This ongoing investment is designed to further enhance the benefit-safety balance of lindane medications.
